A carregar...
Emerging treatment options for the management of Hodgkin’s lymphoma: clinical utility of nivolumab
Classical Hodgkin’s lymphoma (cHL) is a B-cell malignancy comprised of pathologic Reed Sternberg cells with a surrounding immune-tolerant inflammatory milieu. RS cells evade immune recognition in part through programmed death ligand 1 (PD-L1) overexpression, which is genetically programmed through c...
Na minha lista:
| Publicado no: | J Blood Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5436782/ https://ncbi.nlm.nih.gov/pubmed/28546779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S117452 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|